Transcript
BACE Inhibitors Pipeline to Witness Huge R&D Investment in the Coming Years
[email protected]
www.psmarketresearch.com
Beta-Secretase (BACE) Inhibitors Pipeline Analysis
According to a new research report “Beta-Secretase (BACE) Inhibitors Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments” published by P&S Market Research, BACE inhibitors currently exhibit a pipeline with estimated 15 drug candidates. Browse the Report Summary at: https://www.psmarketresearch.com/market-
analysis/beta-secretase-inhibitors-pipeline-analysis
BACE Inhibitors Exhibit an Emerging Pipeline with 10+ Drug Candidates The study analysed that the Beta Secretase inhibitors pipeline comprised 15 drug candidates, in different stages of development.
Beta-Secretase (BACE) Inhibitors Pipeline Analysis
Insights on pipeline segments As per the findings of the research, most of the pipeline drug candidates of BACE inhibitors are being developed to be administered by oral route.
Alzheimer’s disease drug development receives Fast Track designation Among BACE inhibitors, AZD3293, a drug candidate of AstraZeneca plc and Eli Lilly and Company, received Fast Track designation by the U.S. Food and Drug Administration (FDA) in August 2016. The FDA’s Fast Track program was designed to expedite the development and review new therapies to treat serious conditions and tackle unmet medical needs.
Beta-Secretase (BACE) Inhibitors Pipeline Analysis
Major companies collaborate for the development of BACE inhibitors The research finds that different companies collaborated for the development of BACE inhibitors. Novartis entered in a global collaboration with Amgen to commercialize and develop BACE inhibitor program in September 2015 for Alzheimer's disease. Some of the key players developing BACE inhibitors are AstraZeneca plc, Eli Lilly & Company, Johnson & Johnson, and others.
Beta-Secretase (BACE) Inhibitors Pipeline Analysis
Download report sample at:
https://www.psmarketresearch.com/market-analysis/betasecretase-inhibitors-pipeline-analysis/report-sample
GET IN TOUCH
THANK YOU!
For information regarding permissions and other queries
Kindly write to:
[email protected]
US/Canada Toll-Free: 1-888-778-7886
www.psmarketresearch.com
